IDEAYA Biosciences, Inc.
IDYA
$17.45
-$0.90-4.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -72.18M | -130.31M | -51.82M | -52.77M | -39.57M |
| Total Depreciation and Amortization | 1.13M | 643.00K | 1.01M | 1.10M | 1.08M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.46M | 4.57M | 3.85M | 3.09M | -2.00K |
| Change in Net Operating Assets | 4.24M | 3.45M | -2.28M | 15.70M | -5.32M |
| Cash from Operations | -60.34M | -121.66M | -49.23M | -32.88M | -43.81M |
| Capital Expenditure | -1.33M | -1.10M | -457.00K | -973.00K | -1.33M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 81.15M | -196.01M | -19.58M | 69.53M | -352.65M |
| Cash from Investing | 79.82M | -197.11M | -20.04M | 68.56M | -353.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 26.14M | 2.75M | 277.10M | 39.18M | 349.11M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 9.40M | -- | -- |
| Cash from Financing | 26.14M | 2.75M | 286.50M | 39.18M | 349.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 45.62M | -316.01M | 217.23M | 74.86M | -48.67M |